FY
Frank Yan
OtherActivePartner at 3E Bioventures Capital
18
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Frank Yan.
Investment Thesis & Strategy
Frank Yan, as a partner at 3E Bioventures Capital, invests in various stages of biotech and pharmaceutical companies. They seek to partner with innovative companies in the biotech and pharmaceutical industries.
Investment Activity
Deals per year over the last 7 years
1
20121
20130
20140
20155
20162
20171
2018Portfolio Companies
Selected investments from their portfolio of 18 companies
D
Doctor Shaoyang
Healthcare · Seed, 0
L
Ligatech Bioscience
Biotech · Seed, 0
C
Cullgen
Biotech · Series B, 2018
S
Subtle Medical
AI/ML · Series A, 2017
E
Eucure Biopharma
Biotech · Series B, 2017
O
OncoImmune
Biotech · Series B, 2016
C
C4 Therapeutics
Biotech · Series C+, 2016
C
Cytek Biosciences
Biotech · Growth, 2016
R
Refuge Biotechnologies
Biotech · Seed, 2016
E
EpimAb Biotherapeutics
Biotech · Series B, 2016
C
Cardea Bio
Biotech · Series B, 2013
P
Profusa
Biotech · Series B, 2012
Frequently Asked Questions
Frank Yan focuses on Seed stage investments.